![](/img/cover-not-exists.png)
How far should we go with cost-utility analysis when treating children with acute idiopathic thrombocytopenic purpura?
Martin BeneschVolume:
50
Year:
2008
Language:
english
Pages:
1
DOI:
10.1002/pbc.21231
File:
PDF, 54 KB
english, 2008